BioSpace News Archive

Press Releases

Alterity Therapeutics Announces Positive ATH434 Phase 2 Trial Results in Multiple System Atrophy Led By Robust Clinical Efficacy

January 30, 2025
·
12 min read
Press Releases

Cognition’s Positive Phase 2 ‘SHIMMER’ Study of Zervimesine (CT1812) in Dementia with Lewy Bodies (DLB) will be Presented in a Podium Presentation at ILBDC

January 30, 2025
·
9 min read
Press Releases

Allarity Therapeutics Announces Filing of Form 8-K Regarding Settlement Agreement in Principle with SEC

January 30, 2025
·
5 min read
Press Releases

Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics

January 30, 2025
·
4 min read
Press Releases

Cogent Biosciences to Participate in the Guggenheim Biotech Conference

January 30, 2025
·
1 min read
Press Releases

enGene to Present Three Posters at the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU) Highlighting the Ongoing Clinical Development of Detalimogene Voraplasmid for the Treatment of Non-Muscle Invasive Bladder Cancer (NMIBC)

January 30, 2025
·
9 min read
Press Releases

UroGen Pharma to Present at Upcoming Investor Conferences

January 30, 2025
·
1 min read
Press Releases

Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting

January 30, 2025
·
4 min read
Press Releases

Enalare Therapeutics Receives Second Component of a National Institutes of Health (NIH) Grant Award to Fund the Next Human Study of ENA-001

January 30, 2025
·
4 min read
Press Releases

Breakthrough technology for human muscle fatigue measure, Myocene, gets FDA “de novo” approval.

January 30, 2025
·
2 min read